EV/EBITDA
-19.90
+1.21+5.73%
6 min ago
Summary
- As of February 25, 2025, JANX EV/EBITDA is -19.90, with a rise of +1.21 (+5.73%) during the most recent trading day.
- Over the past year, JANX EV/EBITDA has dropped by -9.60 (-93.20%).
- JANX EV/EBITDA is now -423.68% below its all-time high of -3.80.
Performance
JANX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
JANX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.7% | -5.7% | -5.7% |
| 1 m1 month | +27.9% | -27.9% | -27.9% |
| 3 m3 months | +35.1% | -35.1% | -35.1% |
| 6 m6 months | +47.1% | -30.6% | -30.6% |
| ytdytd | +40.3% | -40.3% | -40.3% |
| 1 y1 year | -93.2% | +128.2% | +103.0% |
| 5 y5 years | - | - | - |
JANX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -27.98 | +28.9% | |
| 3 m | 3-month | -19.90 | at high | -42.82 | +53.5% |
| 6 m | 6-month | -19.90 | at high | -42.82 | +53.5% |
| 1 y | 1-year | -10.30 | -93.2% | -44.92 | +55.7% |
| 3 y | 3-year | -3.80 | -423.7% | -44.92 | +55.7% |
| 5 y | 5-year | -3.80 | -423.7% | -130.87 | +84.8% |
| alltime | all time | -3.80 | -423.7% | -130.87 | +84.8% |
Janux Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -19.90(-40.3%) |
| 2024 | -33.33(+373.4%) |
| Date | Value |
|---|---|
| 2023 | -7.04(-10.7%) |
| 2022 | -7.88(-66.8%) |
| 2021 | -23.72 |
FAQ
- What is Janux Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Janux Therapeutics?
- What is JANX EV/EBITDA year-to-date change?
- What is Janux Therapeutics EV/EBITDA year-on-year change?
What is Janux Therapeutics EV/EBITDA?
The current EV/EBITDA of JANX is -19.90
What is the all time high EV/EBITDA for Janux Therapeutics?
Janux Therapeutics all-time high EV/EBITDA is -3.80
What is JANX EV/EBITDA year-to-date change?
Janux Therapeutics EV/EBITDA has changed by +13.43 (+40.29%) since the beginning of the year
What is Janux Therapeutics EV/EBITDA year-on-year change?
Over the past year, JANX EV/EBITDA has changed by -9.60 (-93.20%)